News and Events
- November 05, 2015
TCGA study identifies seven distinct subytypes of prostate cancer
A comprehensive analysis of 333 prostate cancers identified key genetic alterations that may help improve classification and treatment of the disease.
- November 04, 2015
Improved understanding of the genetic drivers of papillary renal cell carcinoma
A comprehensive genomic analysis of 161 tumors from people with papillary renal cell carcinoma (PRCC) – the second most common form of kidney cancer –provided insights into the molecular basis of this cancer and may inform its classification and treatment.
- October 08, 2015
TCGA study identifies genomic features of invasive lobular breast carcinoma
Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified molecular characteristics of a type of breast cancer, invasive lobular carcinoma (ILC), that distinguishes it from invasive ductal carcinoma (IDC), the most common invasive breast cancer subtype.
- June 10, 2015
Brain Tumor’s Genetic Makeup Critical in Treatment, Research Finds
The New York Times describes the important findings from TCGA's research on lower grade gliomas.
- January 27, 2015
Warning: That Tan Could Be Hazardous
The New York Times reports on TCGA data bolstering the case for the link between melanoma and ultraviolet light exposure.
- October 06, 2014
Cancer Genome Sequencing Will Mean More Targeted Therapies
Forbes interviews Dr. Carolyn Hutter, NHGRI team lead for TCGA, about the influence of cancer genomics on the future of precision medicine.
Histopathological image of cerebral glioblastoma.
View All Images >
The difference between a normal cell and cancer cell and how understanding the changes in DNA that cause cancer can help doctors develop better treatments.
View All Videos >
| From the NIH
View All Audio >